Pfizer secures FDA approval for Zavzpret nasal spray to treat migraine
Zavzpret is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray, indicated for the acute treatment…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Mar 23
Zavzpret is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray, indicated for the acute treatment…
10 Mar 23
The company is committed to investing at least $400m and intends to start works on the new biosimilars…
10 Mar 23
In addition, the UPA and AHF are combining their efforts towards maximizing the Egyptian role in promoting the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Mar 23
The late-stage trial compared the lung cancer drug with placebo in the late-stage trial in 682 patients having…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Mar 23
Janssen and its affiliates will get a non-exclusive global license to use Biocytogen’s RenLite platform, and its core…
09 Mar 23
MDX-2201 is ModeX Therapeutics’ preclinical nanoparticle vaccine candidate for Epstein-Barr virus, which is a member of the herpes…
08 Mar 23
This year's Top 30 Women in Food list highlights the Women who are redefining what it means to…
Brand Protection and Anti-counterfeitingCleaning and Disinfection
08 Mar 23
The financing, led by founding investors Polaris Partners and ARCH Venture Partners alongside Lilly, will support Volastra’s portfolio…
08 Mar 23
The CNP analog already has FDA approval in paediatric patients with achondroplasia who are aged five years old…
06 Mar 23
The EC approval was based on results from Phase 2 BEYOND study and allows BMS to commercialise Reblozyl…